Breaking News Instant updates and real-time market news.

DGX

Quest Diagnostics

$87.94

-8.95 (-9.24%)

07:31
11/30/18
11/30
07:31
11/30/18
07:31

Quest Diagnostics price target lowered to $117 from $125 at Barclays

Barclays analyst Jack Meehan lowered his price target for Quest Diagnostics to $117 saying the company's analyst day was "clearly overshadowed" by its lower 2018 forecast. This has been a challenging year for Quest and the new issues are a "negative surprise," Meehan tells investors in a research note. However, he sees merit to sticking with his Overweight thesis for the near-term given a "major 2019 catalyst as national payor networks open access."

  • 03

    Dec

  • 04

    Dec

DGX Quest Diagnostics
$87.94

-8.95 (-9.24%)

11/30/18
GSCO
11/30/18
DOWNGRADE
Target $90
GSCO
Neutral
Quest Diagnostics downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Patrick Donnelly downgraded Quest Diagnostics (DGX) to Neutral and lowered his price target for the shares to $90 from $110. The analyst also downgraded his coverage view of Labs from Attractive to Neutral and removed LabCorp (LH) from his firm's Americans Conviction List. Donnelly's "incrementally more cautious stance" reflects his expectation for continued downward pressure to consensus estimates from ongoing pricing pressure, a "muted" volume outlook, and uncertainty regarding ongoing commercial payer dynamics. He sees an "uneven path to long-term organic volume growth" for Quest.
11/29/18
PIPR
11/29/18
NO CHANGE
PIPR
Quest Diagnostics headwinds are short-term in nature, says Piper Jaffray
Piper Jaffray analyst William Quirk says the headwinds that drove Quest Diagnostics' reduced fiscal 2018 guidance are mostly weather related and short-term in nature. The updated guidance reflects volume softness due to Hurricane Michael, California Wildfires and the recent East Coast weather, Quirk tells investors in a research note. As such, the analyst believes the outlook reduction is "largely a one-time event." He keeps a Neutral rating on the shares with a $110 price target.
11/28/18
PIPR
11/28/18
NO CHANGE
PIPR
Piper sees 'incremental winners' in final Clinical Laboratory Fee Schedule
CareDx (CDNA), Genomic Health (GHDX), LabCorp (LH), Myriad Genetics (MYGN), Natera (NTRA) and Quest Diagnostics (DGX) are the "incremental winners" in the 2019 Final Clinical Laboratory Fee Schedule determinations announced by the Centers for Medicare and Medicaid Services, Piper Jaffray analyst William Quirk tells investors in a research note. Specifically, CMS priced the advanced carrier screening panel at $2,449 versus the code stack method yesterday, Quirk writes. He points out that Genomic Health gets a bump for a couple tests and CareDx competitor TAI Diagnostics ends up with a likely longer pathway to reimbursement.
10/30/18
ARGS
10/30/18
DOWNGRADE
ARGS
Hold
LabCorp downgraded to Hold from Buy at Argus
Argus analyst Jasper Hellweg downgraded LabCorp (LH) to Hold from Buy after its Q3 earnings miss and a cut in FY18 guidance. The analyst notes that the company is faced with pressure from "lower lab testing payment rates mandated by the Protecting Access to Medicaid Act of 2014" along with business disruptions and the impact of acquisitions which resulted in lowers margins for the quarter. Hellweg further cites LabCorp's loss of "status as the exclusive national provider of laboratory services to UnitedHealthcare (UNH)" to rival Quest Diagnostics (DGX). In spite of these short-term challenges, the analyst also maintains a positive outlook for LabCorp on a long-term basis, adding that he would "consider an upgrade if the stock stabilized at the support level of $147 per share."

TODAY'S FREE FLY STORIES

12:45
11/15/19
11/15
12:45
11/15/19
12:45
General news
Breaking General news story  »

Week of 11/15…

BA

Boeing

$371.03

3.73 (1.02%)

, UAL

United Airlines

$92.97

0.43 (0.46%)

12:41
11/15/19
11/15
12:41
11/15/19
12:41
Hot Stocks
United Airlines pulls 737 Max jets off schedule until March 4 »

United Airlines (UAL) is…

BA

Boeing

$371.03

3.73 (1.02%)

UAL

United Airlines

$92.97

0.43 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APDN

Applied DNA Sciences

$4.50

-0.38 (-7.79%)

12:38
11/15/19
11/15
12:38
11/15/19
12:38
Hot Stocks
Empery Asset Management reports 7.17% passive stake in Applied DNA Sciences »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
11/15/19
11/15
12:35
11/15/19
12:35
Hot Stocks
Breaking Hot Stocks news story  »

TKK Symphony Acquisition…

TSLA

Tesla

$349.70

0.19 (0.05%)

, VWAGY

Volkswagen

$0.00

(0.00%)

12:25
11/15/19
11/15
12:25
11/15/19
12:25
Periodicals
VW CEO says company has no plans to cooperate with Tesla, Reuters reports »

Volkswagen (VWAGY) CEO…

TSLA

Tesla

$349.70

0.19 (0.05%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$5.17

0.03 (0.58%)

12:25
11/15/19
11/15
12:25
11/15/19
12:25
Options
Tailored Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

NVDA

Nvidia

$206.25

-3.63 (-1.73%)

, AMZN

Amazon.com

$1,750.30

-4.41 (-0.25%)

12:23
11/15/19
11/15
12:23
11/15/19
12:23
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been higher…

NVDA

Nvidia

$206.25

-3.63 (-1.73%)

AMZN

Amazon.com

$1,750.30

-4.41 (-0.25%)

MSFT

Microsoft

$149.59

1.53 (1.03%)

UAA

Under Armour

$17.82

0.69 (4.03%)

UA

Under Armour

$16.04

0.48 (3.08%)

AMRN

Amarin

$22.89

1.4 (6.51%)

RH

RH

$188.04

12.85 (7.33%)

BRK.A

Berkshire Hathaway

$329,640.00

545 (0.17%)

BRK.B

Berkshire Hathaway

$219.62

0.26 (0.12%)

FTCH

Farfetch

$9.69

2.2 (29.37%)

AMAT

Applied Materials

$62.33

5.44 (9.56%)

ACB

Aurora Cannabis

$3.00

-0.29 (-8.81%)

OXY

Occidental Petroleum

$38.90

1.14 (3.02%)

TORC

resTORbio

$1.16

-6.77 (-85.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 28

    Dec

  • 06

    Jan

TORC

resTORbio

$1.14

-6.79 (-85.62%)

12:21
11/15/19
11/15
12:21
11/15/19
12:21
Downgrade
resTORbio rating change  »

resTORbio downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WE

We Company

$0.00

(0.00%)

12:18
11/15/19
11/15
12:18
11/15/19
12:18
Periodicals
We Company facing SEC probe into possible rule breaches, Bloomberg says »

We Company's WeWork…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCBP

First Choice Bank

$22.49

-0.01 (-0.04%)

12:17
11/15/19
11/15
12:17
11/15/19
12:17
Hot Stocks
First Choice Bancorp announces resignation of CFO Lynn Hopkins »

First Choice Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$120.92

-0.03 (-0.02%)

12:17
11/15/19
11/15
12:17
11/15/19
12:17
Hot Stocks
AmEx reports October consumer card write-off rate 2.3% vs. 2.0% last month »

American Express reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/15/19
11/15
12:17
11/15/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/15/19
11/15
12:16
11/15/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$219.62

1.07 (0.49%)

12:10
11/15/19
11/15
12:10
11/15/19
12:10
Hot Stocks
Amgen treatment of multiple myeloma granted FDA orphan designation »

Amgen's treatment of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

AXGT

Axovant

$4.71

-0.05 (-1.05%)

12:07
11/15/19
11/15
12:07
11/15/19
12:07
Hot Stocks
Axovant granted FDA orphan designation for treatment of GM1 gangliosidosis »

Axovant Sciences was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYFT

Lyft

$43.75

1.85 (4.42%)

, FB

Facebook

$194.64

1.49 (0.77%)

12:05
11/15/19
11/15
12:05
11/15/19
12:05
Recommendations
Lyft, Facebook, Amazon.com, Netflix, Twitter, IAC analyst commentary  »

JPMorgan adds Lyft to…

LYFT

Lyft

$43.75

1.85 (4.42%)

FB

Facebook

$194.64

1.49 (0.77%)

AMZN

Amazon.com

$1,747.79

-6.92 (-0.39%)

NFLX

Netflix

$293.25

3.57 (1.23%)

TWTR

Twitter

$29.38

0.49 (1.70%)

IAC

IAC

$223.02

2.85 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 09

    Dec

  • 10

    Dec

  • 06

    Feb

AUPH

Aurinia Pharmaceuticals

$5.37

0.23 (4.47%)

12:05
11/15/19
11/15
12:05
11/15/19
12:05
Options
Aurinia Pharmaceuticals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:05
11/15/19
11/15
12:05
11/15/19
12:05
General news
Fed Q4 Nowcasts revised lower. »

Fed Q4 Nowcasts revised…

ENVA

Enova International

$22.15

-1.895 (-7.88%)

12:00
11/15/19
11/15
12:00
11/15/19
12:00
Hot Stocks
Enova International falls -8.0% »

Enova International is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANG

Cango

$6.24

-0.6 (-8.77%)

12:00
11/15/19
11/15
12:00
11/15/19
12:00
Hot Stocks
Cango falls -8.4% »

Cango is down -8.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRA

Contura Energy

$8.50

-0.88 (-9.38%)

12:00
11/15/19
11/15
12:00
11/15/19
12:00
Hot Stocks
Contura Energy falls -9.5% »

Contura Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITCB

Itau Corpbanca

$8.63

1.12 (14.91%)

12:00
11/15/19
11/15
12:00
11/15/19
12:00
Hot Stocks
Itau Corpbanca rises 17.7% »

Itau Corpbanca is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

I

Intelsat

$14.89

2.76 (22.75%)

12:00
11/15/19
11/15
12:00
11/15/19
12:00
Hot Stocks
Intelsat rises 22.5% »

Intelsat is up 22.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

FTCH

Farfetch

$9.68

2.19 (29.24%)

12:00
11/15/19
11/15
12:00
11/15/19
12:00
Hot Stocks
Farfetch rises 29.4% »

Farfetch is up 29.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLD

TopBuild

$107.78

-1.78 (-1.62%)

, FBHS

Fortune Brands

$63.13

-0.01 (-0.02%)

11:57
11/15/19
11/15
11:57
11/15/19
11:57
Downgrade
TopBuild, Fortune Brands rating change  »

TopBuild downgraded to…

BLD

TopBuild

$107.78

-1.78 (-1.62%)

FBHS

Fortune Brands

$63.13

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.